Sanofi-aventis | featured news

Sanofi-Aventis to Lay Off 1,700 U.S. Employees

Sanofi-Aventis said it is eliminating 1,700 jobs in its U.S. pharmaceutical business in a restructuring triggered by generic competition and other factors.


Sanofi launches hostile $18.5 billion bid for Genzyme

French drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate.



Subscribe to this RSS topic: Syndicate content